Carisma Therapeutics Closes Merger with Sesen Bio

/PRNewswire/ -- Carisma Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, and...

Related Keywords

University Of Pennsylvania ,Pennsylvania ,United States ,Wellington ,New Zealand General ,New Zealand ,Philadelphia ,Michael Torok ,Sanford Zweifach ,Steven Kelly Carisma ,Thomas Cannell ,Steven Kelly ,Wilmer Cutler Pickering Hale ,Briggs Morrison ,Regina Hodits ,Chidozie Ugwumba ,Securities Exchange Commission ,Hogan Lovells ,Merck Co ,Nasdaq ,Sesen Bio Inc ,Shearman Sterling ,Penn Perelman School Of Medicine ,Carisma Therapeutics Inc ,Bofa Securities Inc ,Ventures Fund ,Sesen Bio ,Carisma Therapeutics ,Nasdaq Capital ,Chief Executive Officer ,Wellington Partners ,Penn Medicine ,Agent Capital ,Pictet Alternative Advisors ,Contingent Value Right ,Roche Asset Purchase ,Carisma President ,Board Sanford ,Bofa Securities ,Cutler Pickering Hale ,Perelman School ,Private Securities Litigation Reform Act ,Securities Exchange ,